Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD: Case Report and Disease Update.

Diagnostics (Basel, Switzerland)·2026
Same author

Missing Opportunity for Nephroprotective Therapy in Patients With Non-Dialysis CKD Under Stable Nephrology Care.

Kidney international reports·2026
Same author

Dialysis Unit Differences in Post-Dialysis Fatigue Prevalence and Characteristics and Time to Recovery After Dialysis.

Hemodialysis international. International Symposium on Home Hemodialysis·2026
Same author

Difelikefalin for CKD-aP: real world evidence of efficacy and safety in Italian patients.

Clinical kidney journal·2025
Same author

Sweeteners: erythritol, xylitol and cardiovascular risk-friend or foe?

Cardiovascular research·2025
Same author

RSPO1, a potent inducer of pancreatic β cell neogenesis.

Cell reports. Medicine·2025

Related Experiment Video

Updated: May 30, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

[L-carnitine in peritoneal dialysis].

Amedeo Franco De Vecchi1, Arduino Arduini, Lorenzo Di Liberato

  • 1Casa di Cura Multimedica, Milano and Dipartimento Ricerca e Sviluppo, Glomeria Therapeutics Srl, Chieti, Italy. amedeo.devecchi@fastwebnet.it

Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|August 3, 2011
PubMed
Summary

L-carnitine supplementation shows potential benefits for dialysis patients, including improved lipid metabolism and reduced insulin resistance. However, research in hemodialysis and peritoneal dialysis patients yields controversial results, necessitating further investigation into optimal dosing and efficacy.

More Related Videos

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

Related Experiment Videos

Last Updated: May 30, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

Area of Science:

  • Biochemistry
  • Cell Biology
  • Metabolic Medicine

Context:

  • L-carnitine is crucial for fatty acid transport and cellular energy metabolism.
  • Its role in dialysis patients, particularly in hemodialysis and peritoneal dialysis, is under investigation due to mixed findings.
  • Current research faces challenges including small sample sizes and varied methodologies.

Purpose:

  • To review the existing literature on L-carnitine supplementation in dialysis patients.
  • To highlight the controversial outcomes and methodological limitations in previous studies.
  • To explore the potential of L-carnitine in improving metabolic parameters and cell protection in dialysis.

Summary:

  • L-carnitine supplementation has demonstrated potential in improving insulin resistance, lipid metabolism, and erythrocyte rheology.
  • Studies in hemodialysis patients show conflicting results regarding L-carnitine's efficacy.
  • Peritoneal dialysis research indicates potential benefits in reducing apolipoprotein B and protecting cells, with ongoing studies exploring combined glucose-carnitine solutions.

Impact:

  • L-carnitine may be considered a conditional drug for certain metabolic conditions.
  • Further well-designed clinical trials are needed to establish optimal L-carnitine dosing and confirm its benefits in dialysis patients.
  • Investigating L-carnitine in peritoneal dialysis solutions could offer new therapeutic strategies for patients undergoing this treatment modality.